Prevention and treatment of Patent Ductus Arteriosus: Evidence from systematic reviews

The Cochrane Neonatal Review Group is pleased to announce the fourteenth in a series of sessions focused on specific Cochrane Reviews and the evidence that they provide for practice.

We will be presenting a web seminar: “Prevention and treatment of Patent Ductus Arteriosus: Evidence from systematic reviews”.  The web seminar will be held on June 22, 2016 at 12:00 Eastern Daylight Time (UTC-4 hours).

The goal of this session is to understand the evidence regarding prevention and treatment of Patent Ductus Arteriosus. 

The webinar is available free to all neonatal physicians, practitioners and trainees. 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Vermont College of Medicine and The Cochrane Neonatal Review Group. The University of Vermont College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Vermont designates this live activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

We hope that this will be an exciting format for discussion of how these interventions can improve neonatal care.

To register please complete this survey: https://www.surveymonkey.com/r/VNRN3LY

Contact and info:

Yolanda Brosseau (yolanda.brosseau@uvm.edu)